ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹12 Cr | ₹0.11 Cr | ₹-8.27 Cr | ₹-6.36 Cr | ₹-1.59 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹-8.27 Cr |
| Mar2023 | ₹-6.36 Cr |
| Mar2022 | ₹-1.59 Cr |
How is Cash Flow from Financing Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | 10,738.18 | |
| Mar2025 | ₹0.11 Cr | Positive | |
| Mar2024 | ₹-8.27 Cr | Negative | |
| Mar2023 | ₹-6.36 Cr | Negative | |
| Mar2022 | ₹-1.59 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹495.2 Cr | 4% | 27.2% | 9.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 4% |
27.2% |
9.6% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses